Clinical trial
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
NCT00842283 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- Lead sponsor
- University of California, Irvine
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 30, 2008
- Completion date
- December 31, 2028
- Enrollment
- 85 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
dermatologic diseases